A complementary approach to treating antibody-mediated transplant rejection
- PMID: 20588285
- DOI: 10.1038/ki.2010.80
A complementary approach to treating antibody-mediated transplant rejection
Abstract
Current treatment for antibody-mediated kidney transplant rejection is inadequate. Tillou and colleagues administered recombinant C1 inhibitor to block complement activation to prevent antibody-initiated injury in sensitized baboon recipients of kidney allografts. These early but encouraging results support further testing of the safety and efficacy of complement inhibition as part of a comprehensive strategy to treat this disease, both in animal models and ultimately in humans.
Comment on
-
Recombinant human C1-inhibitor prevents acute antibody-mediated rejection in alloimmunized baboons.Kidney Int. 2010 Jul;78(2):152-9. doi: 10.1038/ki.2010.75. Epub 2010 Mar 24. Kidney Int. 2010. PMID: 20336054
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
